Inventor · disambiguated record
Hiroshi Sootome
Also filed as: SOOTOME HIROSHI
8 granted patents·3 pending applications·32 citations·filing 2013–2021
84Inventor score
Files withTAIHO PHARMACEUTICAL CO LTD11
Top patents by PatentIndex Score
11 records- 0190US10835536B2Therapeutic agent for FGFR inhibitor-resistant cancerTAIHO PHARMACEUTICAL CO LTD·Filed 2018·Granted Nov 17, 2020·5 cites·31 claims
- 0289US10124003B2Therapeutic agent for FGFR inhibitor-resistant cancerTAIHO PHARMACEUTICAL CO LTD·Filed 2014·Granted Nov 13, 2018·8 cites·8 claims
- 0384US11883404B2Preparation and composition for treatment of malignant tumorsTAIHO PHARMACEUTICAL CO LTD·Filed 2019·Granted Jan 30, 2024·2 cites·13 claims
- 0484US9012475B2Method for enhancing anti-tumor effect of a microtubule-targeting drug, and a method for treatment of tumorTAIHO PHARMACEUTICAL CO LTD·Filed 2013·Granted Apr 21, 2015·4 cites·12 claims
- 0583US9108973B23,5-disubstituted alkynylbenzene compound and salt thereofTAIHO PHARMACEUTICAL CO LTD·Filed 2013·Granted Aug 18, 2015·8 cites·10 claims
- 0679US9346787B2Piperidine compound or salt thereofTAIHO PHARMACEUTICAL CO LTD·Filed 2013·Granted May 24, 2016·3 cites·16 claims
- 0777US11975002B2Preparation and composition for treatment of malignant tumorsTAIHO PHARMACEUTICAL CO LTD·Filed 2017·Granted May 7, 2024·1 cites·30 claims
- 0872US10092556B2Piperidine compound or salt thereofTAIHO PHARMACEUTICAL CO LTD·Filed 2016·Granted Oct 9, 2018·1 cites·21 claims
- 0956US2018369224A1Novel piperidine compound or salt thereofTAIHO PHARMACEUTICAL CO LTD·Filed 2018·Application pending·0 cites
- 1055US2023181536A1Anticancer combination therapy with n-(1-acryloyl-azetidin-3-yl)-2-((1h-indazol-3-yl)amino)methyl)-1h-imidazole-5-carboxamide inhibitor of kras-g12cTAIHO PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 1153US2022023300A1Therapeutic and prophylactic method for tumor treatable with endocrine therapy by combined use of fibroblast growth factor receptor inhibitor with endocrine therapyTAIHO PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →